United States · FDA National Drug Code directory
Bromocriptine Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-978_009f6f28-14a8-4d34-a24c-b09e90572739
- Product NDC
- 70954-978
- Form
- TABLET
- Composition / generic term
- Bromocriptine Mesylate
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250615
- Source listing expiry
- 20271231
Source-listed ingredients
- BROMOCRIPTINE MESYLATE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (70954-978-10) · 70954-978-10
- 100 TABLET in 1 BOTTLE (70954-978-20) · 70954-978-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →